nach oben

Diabetologia

Erschienen in:

01.08.2011 | Article

mRNA of the pro-apoptotic gene BBC3 serves as a molecular marker for TNF-α-induced islet damage in humans

verfasst von: K. Omori, M. Mitsuhashi, K. Ishiyama, I. Nair, J. Rawson, I. Todorov, F. Kandeel, Y. Mullen

Erschienen in: Diabetologia | Ausgabe 8/2011

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

TNF-α plays important roles in the pathogenesis of type 1 and type 2 diabetes mellitus. In light of this, we examined the involvement of a pro-apoptotic gene, BBC3 (also known as PUMA), in TNF-α-mediated beta cell dysfunction and destruction in human islets.

Methods

Human islets were exposed in vitro to TNF-α alone or in combination with IFN-γ. Gene expression was assessed by RT-PCR using a set of single islets. Protein abundance and cellular localisation of BBC3 were assessed by immunoblot and immunohistochemistry. A marginal number of islets were transplanted into diabetic NODscid mice to correlate in vivo islet function with BBC3 expression.

Results

BBC3 and IL8 mRNA were upregulated in TNF-α-stimulated islets in a dose-dependent manner and enhanced through addition of IFN-γ, but not upregulated by IFN-γ alone. Immunohistochemistry revealed that TNF-α in combination with IFN-γ upregulated basal BBC3 abundance in the cytoplasm of beta cells along with the perinuclear clustering of mitochondria partially co-localised with BBC3. TNF-α alone did not induce beta cell death, but did abrogate preproinsulin precursor mRNA synthesis in response to high glucose stimulation, which was inversely associated with upregulation of BBC3 mRNA expression by TNF-α. Higher BBC3 mRNA expression in islets correlated with decreased graft function in vivo.

Conclusions/interpretation

These results suggest that BBC3 mRNA can serve as a molecular marker to detect early TNF-α-induced beta cell stress and may help identify islet-protective compounds for the treatment of diabetes.

Nur mit Berechtigung zugänglich

Eizirik DL, Mandrup-Poulsen T (2001) A choice of death—the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44:2115–2133PubMedCrossRef

Stephens LA, Thomas HE, Ming L et al (1999) Tumor necrosis factor-alpha-activated cell death pathways in NIT-1 insulinoma cells and primary pancreatic beta cells. Endocrinology 140:3219–3227PubMedCrossRef

Picarella DE, Kratz A, Li CB, Ruddle NH, Flavell RA (1993) Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. J Immunol 150:4136–4150PubMed

Satoh J, Seino H, Abo T et al (1989) Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice. J Clin Invest 84:1345–1348PubMedCrossRef

Yang XD, Tisch R, Singer SM et al (1994) Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J Exp Med 180:995–1004PubMedCrossRef

Suk K, Kim S, Kim YH et al (2001) IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death. J Immunol 166:4481–4489PubMed

Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM (1994) Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91:4854–4858PubMedCrossRef

Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389:610–614PubMedCrossRef

Steinberg GR, Michell BJ, van Denderen BJ et al (2006) Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab 4:465–474PubMedCrossRef

10.

Bouzakri K, Zierath JR (2007) MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance. J Biol Chem 282:7783–7789PubMedCrossRef

11.

Tesz GJ, Guilherme A, Guntur KV et al (2007) Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2. J Biol Chem 282:19302–19312PubMedCrossRef

12.

Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev 3:745–756

13.

Wajant H, Pfizenmaier K, Scheurich P (2003) Tumor necrosis factor signaling. Cell Death Differ 10:45–65PubMedCrossRef

14.

Hengartner MO (2000) The biochemistry of apoptosis. Nature 407:770–776PubMedCrossRef

15.

Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116:205–219PubMedCrossRef

16.

McKenzie MD, Carrington EM, Kaufmann T et al (2008) Proapoptotic BH3-only protein Bid is essential for death receptor-induced apoptosis of pancreatic beta-cells. Diabetes 57:1284–1292PubMedCrossRef

17.

Grunnet LG, Aikin R, Tonnesen MF et al (2009) Proinflammatory cytokines activate the intrinsic apoptotic pathway in beta-cells. Diabetes 58:1807–1815PubMedCrossRef

18.

Gurzov EN, Germano CM, Cunha DA et al (2010) p53 up-regulated modulator of apoptosis (PUMA) activation contributes to pancreatic beta cell apoptosis induced by pro-inflammatory cytokines and endoplasmic reticulum stress. J Biol Chem 285:19910–19920PubMedCrossRef

19.

Sun Q, Ming L, Thomas SM et al (2009) PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells. Oncogene 28:2348–2357PubMedCrossRef

20.

Vousden KH (2005) Apoptosis. p53 and PUMA: a deadly duo. Science 309:1685–1686PubMedCrossRef

21.

Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L (2003) PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci USA 100:1931–1936PubMedCrossRef

22.

You H, Pellegrini M, Tsuchihara K et al (2006) FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal. J Exp Med 203:1657–1663PubMedCrossRef

23.

Reimertz C, Kogel D, Rami A, Chittenden T, Prehn JH (2003) Gene expression during ER stress-induced apoptosis in neurons: induction of the BH3-only protein Bbc3/PUMA and activation of the mitochondrial apoptosis pathway. J Cell Biol 162:587–597PubMedCrossRef

24.

Wang P, Qiu W, Dudgeon C et al (2009) PUMA is directly activated by NF-kappaB and contributes to TNF-alpha-induced apoptosis. Cell Death Differ 16:1192–1202PubMedCrossRef

25.

Omori K, Mitsuhashi M, Todorov I et al (2010) Microassay for glucose-induced preproinsulin mRNA expression to assess islet functional potency for islet transplantation. Transplantation 89:146–154PubMedCrossRef

26.

Mitsuhashi M, Targan SR (2008) Ex vivo simulation of IgG Fc and T cell receptor functions: an application to inflammatory bowel disease. Inflamm Bowel Dis 14:1061–1067PubMedCrossRef

27.

Mitsuhashi M, Tomozawa S, Endo K, Shinagawa A (2006) Quantification of mRNA in whole blood by assessing recovery of RNA and efficiency of cDNA synthesis. Clin Chem 52:634–642PubMedCrossRef

28.

Mitsuhashi M, Endo K, Obara K, Izutsu H, Ishida T, Chikatsu N, Shinagawa A (2008) Quantification of drug-induced mRNA in human whole blood ex vivo. Clinical Medicine: Blood Disorders 1:1–11, Available from www.la-press.com/quantification-of-drug-induced-mrna-in-humanwhole-blood-ex-vivo-a491. Accessed 1 May 2011

29.

Omori K, Valiente L, Orr C et al (2007) Improvement of human islet cryopreservation by a p38 MAPK inhibitor. Am J Transplant 7:1224–1232PubMedCrossRef

30.

Todorov I, Nair I, Avakian-Mansoorian A et al (2010) Quantitative assessment of beta-cell apoptosis and cell composition of isolated, undisrupted human islets by laser scanning cytometry. Transplantation 90:836–842PubMedCrossRef

31.

Itakura S, Asari S, Rawson J et al (2007) Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat. Am J Transplant 7:336–346PubMedCrossRef

32.

Ito T, Omori K, Rawson J et al (2008) Improvement of canine islet yield by donor pancreas infusion with a p38MAPK inhibitor. Transplantation 86:321–329PubMedCrossRef

33.

Hanley S, Liu S, Lipsett M et al (2006) Tumor necrosis factor-alpha production by human islets leads to postisolation cell death. Transplantation 82:813–818PubMedCrossRef

34.

Mastrandrea L, Yu J, Behrens T et al (2009) Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study. Diabetes Care 32:1244–1249PubMedCrossRef

35.

Hagerkvist R, Sandler S, Mokhtari D, Welsh N (2007) Amelioration of diabetes by imatinib mesylate (Gleevec): role of beta-cell NF-kappaB activation and anti-apoptotic preconditioning. FASEB J 21:618–628PubMedCrossRef

36.

Matsuda T, Omori K, Vuong T et al (2005) Inhibition of p38 pathway suppresses human islet production of pro-inflammatory cytokines and improves islet graft function. Am J Transplant 5:484–493PubMedCrossRef

37.

Omori K, Todorov I, Shintaku J et al (2010) P38alpha-selective mitogen-activated protein kinase inhibitor for improvement of cultured human islet recovery. Pancreas 39:436–443PubMedCrossRef

38.

Eizirik DL, Colli ML, Ortis F (2009) The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev 5:219–226

39.

Donath MY, Storling J, Maedler K, Mandrup-Poulsen T (2003) Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med (Berlin, Germany) 81:455–470

40.

De Vos K, Goossens V, Boone E et al (1998) The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membrane-proximal region. J Biol Chem 273:9673–9680PubMedCrossRef

41.

Desagher S, Martinou JC (2000) Mitochondria as the central control point of apoptosis. Trends Cell Biol 10:369–377PubMedCrossRef

42.

Niizuma K, Endo H, Nito C, Myer DJ, Chan PH (2009) Potential role of PUMA in delayed death of hippocampal CA1 neurons after transient global cerebral ischemia. Stroke 40:618–625PubMedCrossRef

43.

Kwon G, Xu G, Marshall CA, McDaniel ML (1999) Tumor necrosis factor alpha-induced pancreatic beta-cell insulin resistance is mediated by nitric oxide and prevented by 15-deoxy-Delta12,14-prostaglandin J2 and aminoguanidine. A role for peroxisome proliferator-activated receptor gamma activation and inos expression. J Biol Chem 274:18702–18708PubMedCrossRef

44.

Kim HE, Choi SE, Lee SJ et al (2008) Tumour necrosis factor-alpha-induced glucose-stimulated insulin secretion inhibition in INS-1 cells is ascribed to a reduction of the glucose-stimulated Ca²⁺ influx. J Endocrinol 198:549–560PubMedCrossRef

Titel: mRNA of the pro-apoptotic gene BBC3 serves as a molecular marker for TNF-α-induced islet damage in humans
verfasst von: K. Omori
M. Mitsuhashi
K. Ishiyama
I. Nair
J. Rawson
I. Todorov
F. Kandeel
Y. Mullen
Publikationsdatum: 01.08.2011
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 8/2011
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-011-2183-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2011

Disturbed subjective sleep characteristics in adult patients with long-standing type 1 diabetes mellitus

Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia

Genome-wide association and meta-analysis in populations from Starr County, Texas, and Mexico City identify type 2 diabetes susceptibility loci and enrichment for expression quantitative trait loci in top signals

A novel role for vitamin D: modulation of expression and function of the local renin–angiotensin system in mouse pancreatic islets

The previously reported T342P GCK missense variant is not a pathogenic mutation causing MODY